Share Prices & Company Research

Stockbroking

Motif Bio Ord 1p

Current Price 0.49p Bid 0.49p Ask 0.50p Change 0.00%
Last Updated: 13/11/2019 03:00. Prices delayed by at least 15 minutes.
Call 0113 243 6941 or search for your local office

Company Overview

Motif Bio plc is a clinical-stage biopharmaceutical company focused on developing novel antibiotics designed to be effective against serious and life-threatening infections caused by multi-drug resistant Gram-positive bacteria, including MRSA. The Company's lead product candidate is iclaprim. Motif Bio is seeking approval of iclaprim from the U.S. Food & Drug Administration (FDA) for the treatment of acute bacterial skin and skin structure infections (ABSSSI). More than 3.6 million patients with ABSSSI are hospitalised annually in the U.S. It is estimated that up to 26% of hospitalized ABSSSI patients have renal impairment. The Company also has plans to develop iclaprim for hospital acquired bacterial pneumonia (HABP), including ventilator associated bacterial pneumonia (VABP), as there is a high unmet need for new therapies in this indication.

Financial Highlights Year Ended 31/12/2018

Turnover
£0.00m
Operating Profit
£-18.62m
Dividend Yield
0.00
Dividend Per Share
0.00
Dividend Cover
0.00
P/E Ratio
-0.09

Key Personnel

Graham George Lumsden
Chief Executive Officer
Jonathan E Gold
Int Chief Financial Officer
Andrew Kenneth Williams Powell
Non-Executive Director
Dr Mary Lake Polan
Non-Executive Director
Zaki Hosny
Non-Executive Director
Maria Charlotta Ginman
Non-Executive Director
Dr Craig Albanese
Non-Executive Director
Bruce Andrew Williams
Non-Executive Int Chairman

Stock Details

EPIC
MTFB
ISIN
GB00BVVT4H71
Shares in Issue
342,491,023
Market cap
£1.58m
Sector

Analyst Views (1)

Strong Buy
 
0.00%
Buy
 
0.00%
Hold
 
100.00%
Sell
 
0.00%
Strong Sell
 
0.00%
The above information represents a selection of the views published in the last 120 days by analysts. It is subject to change without notice and doesn't reflect view held by Redmayne Bentley and is not advice.

Price Summary

Mid Price
0.00p
Bid Price
0.49p
Ask Price
0.50p
Volume
0
Change Today
0.00p
% Change Today
0.00%
Open
0.00p
Previous Close
0.50p
Intraday High
0.00p
Intraday Low
0.00p
52 Week High
44.90p
52 Week Low
0.42p
52 week high and low figures quoted above are calculated from intraday price data.

Intra-Day Chart

Motif Bio  Ord 1p Intra-day Chart

Assets (£m)

Data has been provided by AJ Bell

Reporting Date
31 Dec 2018
31 Dec 2017
Tangible Assets
0.0
0.0
Intangible Assets & Goodwill
6.2
6.2
Investments & Other Non-Current Assets
0.0
0.0
Total Non-Current Assets
6.2
6.2
Inventory
0.0
0.0
Trade & Receivables
0.2
0.3
Cash & Receivables
12.3
22.7
Other Current Assets & Assets Held for Resale
0.0
0.0
Total Assets
18.7
29.2

Liabilities (£m)

Data has been provided by AJ Bell

Reporting Date
31 Dec 2018
31 Dec 2017
Short Term Liabilities
17.3
24.0
Long Term Liabilities
10.3
14.1
Other Liabilities / Pension etc
0.0
0.0
Total Liabilities
27.7
38.1

Net Assets (£m)

Data has been provided by AJ Bell

Reporting Date
31 Dec 2018
31 Dec 2017
Net Assets
-8.9
-8.9

Equity (£m)

Data has been provided by AJ Bell

Reporting Date
31 Dec 2018
31 Dec 2017
Share Capital
4.0
3.6
Minority Interests
0.0
0.0
Retained Earnings
-116.4
-103.3
Share Premium Account
93.5
80.9
Other Equity
9.9
9.9
Total Equity
-8.9
-8.9

Cashflow (£m)

Data has been provided by AJ Bell

Reporting Date
31 Dec 2018
31 Dec 2017
Cashflow from Operating Activities
-21.5
-37.4
Cashflow Before Financing
-21.5
-37.4
Increase / Decrease in Cash
-10.2
1.0

Income (£m)

Data has been provided by AJ Bell

Reporting Date
31 Dec 2018
31 Dec 2017
Turnover
0.0
0.0
Cost of Sales
0.0
0.0
Gross Profit
0.0
0.0
Operating Profit
-18.6
-38.0
Pre-Tax Profit
-14.0
-44.8
Profit / Loss for the Year
-14.0
-44.8
The value of your investments and the income from them may go down as well as up, and you could get back less than you invested.
We use cookies on this site to improve your experience and help us provide you with a better website. An explanation of the cookies we use and their purpose can be found within our Cookie Policy. Your continued use of this site means you consent to the use of cookies.